Daily Courier: Single Column

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

472.74 +3.06 (+0.65%)
Streaming Delayed Price Updated: 12:58 PM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 434,895
Open 467.73
Bid (Size) 472.64 (120)
Ask (Size) 472.84 (40)
Prev. Close 469.68
Today's Range 467.06 - 475.33
52wk Range 362.50 - 519.68
Shares Outstanding 259,428,394
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Cashing In at the Peak: Olema Pharmaceuticals Insiders Sell $8 Million in Stock After 300% Surge
Olema Pharmaceuticals (NASDAQ:OLMA) has become the latest focal point of biotech volatility and executive opportunism. Following a staggering 300% surge in its share price over the past year—fueled by... 
Via MarketMinute
News headline image
Prediction: 2 Healthcare Stocks That Will Be Worth More Than Pfizer by the End of 2026 ↗
It could be another tough year for the once-soaring drugmaker. 
Via The Motley Fool
Topics Intellectual Property

Performance

YTD
+4.6%
+4.6%
1 Month
+8.2%
+8.2%
3 Month
+14.0%
+14.0%
6 Month
-1.4%
-1.4%
1 Year
+14.7%
+14.7%

More News

Read More
News headline image
Moderna’s Second Act: Analyzing the 2026 Pipeline Pivot and Recent Stock Surge
Via PredictStreet
Topics Economy Initial Public Offering Intellectual Property
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Emerges as a Compelling Value Stock Candidate ↗
Via Chartmill
News headline image
Stocks making big moves yesterday: Herbalife, Vertex Pharmaceuticals, Micron, Amkor, and Palantir Technologies
Via StockStory
Topics Artificial Intelligence
News headline image
Vertex Pharmaceuticals (VRTX) Stock Trades Up, Here Is Why
Via StockStory
News headline image
My 10 Top Stocks to Buy to Start the New Year Off Right ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
BofA Unveils Q1 2026 Top Stock Picks: High-Conviction Bets on AI Infrastructure and Health Care Valuations
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
The Best Stocks to Invest $1,000 in to Start the New Year Off Right ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Biotech’s Resurgence: How a Year-End Rally and M&A Frenzy Set the Stage for 2026
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
Stay informed with the top movers within the S&P500 index on Tuesday. ↗
Via Chartmill
News headline image
Discover which S&P500 stocks are making waves on Tuesday. ↗
Via Chartmill
News headline image
2 Growth Stocks to Buy For 2026 and Beyond ↗
Via The Motley Fool
Topics Economy
News headline image
2 Nasdaq 100 Stocks Worth Investigating and 1 We Turn Down
Via StockStory
Topics Electric Vehicles World Trade
News headline image
3 Supercharged Growth Stocks to Buy and Hold Into the 2030s ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Forget Moderna Stock, This is a Much Better Buy ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
The $1.7 Billion Pivot: Agios Pharmaceuticals (AGIO) and the New Frontier of Oral Thalassemia Therapy
Via PredictStreet
Topics Economy
News headline image
Is CRISPR Therapeutics Stock Yesterday's News? ↗
Via The Motley Fool
News headline image
Vertex to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
Moderna (MRNA): The “Act 2” of an mRNA Pioneer – A 2025 Deep Dive
Via PredictStreet
Topics Earnings Initial Public Offering Intellectual Property
News headline image
Vertex Pharmaceuticals Inc (NASDAQ:VRTX): A GARP Case Study in Affordable Growth ↗
Via Chartmill
News headline image
2 Cash-Producing Stocks to Consider Right Now and 1 We Find Risky
Via StockStory
News headline image
Is CRISPR Therapeutics a Buy, Sell, or Hold in 2026? ↗
Via The Motley Fool
News headline image
2 Reasons to Watch VRTX and 1 to Stay Cautious
Via StockStory
Topics Stocks
News headline image
From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes
From USA News Group
Via GlobeNewswire

Frequently Asked Questions

Is Vertex Pharmaceuticals publicly traded?
Yes, Vertex Pharmaceuticals is publicly traded.
What exchange does Vertex Pharmaceuticals trade on?
Vertex Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Vertex Pharmaceuticals?
The ticker symbol for Vertex Pharmaceuticals is VRTX on the Nasdaq Stock Market
What is the current price of Vertex Pharmaceuticals?
The current price of Vertex Pharmaceuticals is 472.74
When was Vertex Pharmaceuticals last traded?
The last trade of Vertex Pharmaceuticals was at 01/09/26 12:58 PM ET
What is the market capitalization of Vertex Pharmaceuticals?
The market capitalization of Vertex Pharmaceuticals is 122.64B
How many shares of Vertex Pharmaceuticals are outstanding?
Vertex Pharmaceuticals has 123B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Daily Courier, Kelowna, BC. Powered by BLOX Content Management System from TownNews.com.